National Health Investors (NHI) Cash & Equivalents (2009 - 2026)

National Health Investors has reported Cash & Equivalents for 18 years, with the latest figure at $24.9 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 81.52% year-over-year to $24.9 million; the trailing twelve-month figure through Mar 2026 stood at $24.9 million (down 81.52% YoY), and the FY2025 full-year result was $19.6 million, down 19.21% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $24.9 million, up from $19.6 million in the prior quarter.
• The five-year high for Cash & Equivalents was $135.0 million in Q1 2025, with the low at $11.4 million in Q1 2024.
• Historically, Cash & Equivalents has averaged $32.0 million across 5 years, with a median of $19.6 million in 2025.
• Annual changes were most pronounced in 2025 — Cash & Equivalents jumped 1088.73% — and 2026, when it tumbled 81.52%.
• National Health Investors' Cash & Equivalents stood at $19.3 million in 2022, then climbed by 15.84% to $22.3 million in 2023, then grew by 8.69% to $24.3 million in 2024, then decreased by 19.21% to $19.6 million in 2025, then gained by 27.13% to $24.9 million in 2026.
• The last three Cash & Equivalents figures came in at $24.9 million (Q1 2026), $19.6 million (Q4 2025), and $81.6 million (Q3 2025), per Business Quant data.